{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:20:36Z","timestamp":1760188836656},"reference-count":16,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T00:00:00Z","timestamp":1133222400000},"content-version":"vor","delay-in-days":6907,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1987,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cyclosporine (10 mg\/kg\/day) and azathioprine (2.5\u20133 mg\/kg\/day) were compared for 26 weeks in an open, controlled, randomized study of 24 patients with rheumatoid arthritis. Each treatment group consisted of 12 patients. Those patients who took cyclosporine improved significantly in the 50\u2010foot walk time, circumferences of proximal interphalangeal joints, Ritchie articular index, global assessment by investigator, and grip strength, when compared with baseline findings. In the azathioprine group, there was improvement only in grip strength.<\/jats:p>","DOI":"10.1002\/art.1780300112","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T21:48:31Z","timestamp":1171489711000},"page":"88-92","source":"Crossref","is-referenced-by-count":72,"title":["An Open, Controlled, Randomized Comparison of Cyclosporine and Azathioprine in the Treatment of Rheumatoid Arthritis: A Preliminary Report"],"prefix":"10.1002","volume":"30","author":[{"given":"\u00d8Ystein","family":"F\u00d8Rre","sequence":"first","affiliation":[]},{"given":"Frithjof","family":"Bjerkhoel","sequence":"additional","affiliation":[]},{"given":"Christian F.","family":"Salvesen","sequence":"additional","affiliation":[]},{"given":"Knut J.","family":"Berg","sequence":"additional","affiliation":[]},{"given":"Hans E.","family":"Rugstad","sequence":"additional","affiliation":[]},{"given":"Gunnar","family":"Saelid","sequence":"additional","affiliation":[]},{"given":"Ove J.","family":"Mellbye","sequence":"additional","affiliation":[]},{"given":"Erik","family":"K\u00c5Ss","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2005,11,29]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-6-810"},{"key":"e_1_2_1_3_2","first-page":"63","article-title":"Interleukin 2 production by peripheral blood synovial fluid and synovial tissue lymphocytes (abstract)","volume":"1","author":"F\u00f8rre \u00d8","year":"1982","journal-title":"Clin Rheumatol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.151.6.1551"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6334364"},{"key":"e_1_2_1_6_2","first-page":"237","article-title":"Effects of the antilymphocytic agent cyclosporin A in chronic inflammation","volume":"1","author":"Borel JF","year":"1978","journal-title":"Eur J Rheumatol Inflamm"},{"key":"e_1_2_1_7_2","first-page":"175","article-title":"1958 revision of diagnostic criteria for rheumatoid arthritis","volume":"9","author":"Ropes MW","year":"1958","journal-title":"Bull Rheum Dis"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1949.02900430001001"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748409111299"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(82)90033-3"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","unstructured":"HuskissonEC: Azathioprine Antirheumatic Drugs II. Edited by EC Huskisson. Clin Rheum Dis 10:325\u2013332 1984","DOI":"10.1016\/S0307-742X(21)00505-1"},{"key":"e_1_2_1_12_2","first-page":"173","article-title":"Die Therapie der chronischen Polyarthritis mit cyclosporin A, einem neuen","volume":"4","author":"Herrman B","year":"1979","journal-title":"Immunosuppressivum Akt Rheumatol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90230-1"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6367043"},{"key":"e_1_2_1_15_2","first-page":"2706","article-title":"Renal failure (RF) in heart transplant patients receiving cyclosporine","volume":"15","author":"Egel J","year":"1983","journal-title":"Transplant Proc"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90356-5"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.125"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780300112","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780300112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T08:23:34Z","timestamp":1700727814000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780300112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1987,1]]}},"alternative-id":["10.1002\/art.1780300112"],"URL":"https:\/\/doi.org\/10.1002\/art.1780300112","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,1]]}}}